Effect of gemfibrozil on the pharmacokinetics of pioglitazone
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00228-005-0042-6.pdf
Reference15 articles.
1. Füchtenbusch M, Standl E, Schatz H (2000) Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 108:151–163
2. Kiyota Y, Kondo T, Maeshiba Y (1997) Studies on the metabolism of the new antidiabetic agent pioglitazone. Identification of metabolites in rats and dogs. Arzneimittelforschung 47:22–28
3. Tanis SP, Parker TT (1996) Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent Pioglitazone. J Med Chem 39:5053–5063
4. Hiraga K (1997) Clinical phase 1 study of AD-4833: single-dose and repeated-dose studies. Jpn J Clin Exp Med 74:1184–1201
5. Niemi M, Backman JT, Granfors M, Laitila J (2003) Gemfibrozil considerably increases the plasma concentration of rosiglitazone. Diabetologia 46:1319–1323
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Caffeine modulates pharmacokinetic and pharmacodynamic profiles of pioglitazone in diabetic rats;Saudi Medical Journal;2021-02
2. Physiologically Based Pharmacokinetic Models for Prediction of Complex CYP2C8 and OATP1B1 (SLCO1B1) Drug–Drug–Gene Interactions: A Modeling Network of Gemfibrozil, Repaglinide, Pioglitazone, Rifampicin, Clarithromycin and Itraconazole;Clinical Pharmacokinetics;2019-05-25
3. Clopidogrel and Gemfibrozil Strongly Inhibit the CYP2C8-Dependent Formation of 3-Hydroxydesloratadine and Increase Desloratadine Exposure In Humans;Drug Metabolism and Disposition;2019-01-10
4. The drug interaction potential of daprodustat when coadministered with pioglitazone, rosuvastatin, or trimethoprim in healthy subjects;Pharmacology Research & Perspectives;2018-03-09
5. Clopidogrel but Not Prasugrel Significantly Inhibits the CYP2C8-Mediated Metabolism of Montelukast in Humans;Clinical Pharmacology & Therapeutics;2017-12-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3